文献速递神经肿瘤

大至巨大垂体腺瘤经颅手术后视觉功能变化的手术结局与预测因素

Surgical Outcomes and Predictors of Visual Function Alterations After Transcranial Surgery for Large-to-Giant Pituitary Adenomas.
PubMed 文献 · World Neurosurg · 2020-04-27

该研究纳入37例大至巨大垂体腺瘤患者,评估经颅手术后视力与视野的视觉损伤评分变化。术后43.2%患者视觉功能改善、43.2%稳定、13.5%恶化;多因素logistic回归显示蛛网膜下腔侵犯是唯一独立不良预后因素。

要点

  • 经颅手术治疗大至巨大垂体腺瘤后,13.5%患者视觉功能恶化。
  • 术前MRI示蛛网膜下腔侵犯是术后视觉结局的独立负面预测因素。
  • 有蛛网膜下腔侵犯者术后视觉恶化风险更高(36.4% vs. 3.8%,P=0.021)。

核心结论

  • 视觉损害仍是大至巨大垂体腺瘤经颅手术不可忽视的并发症。
  • 术前MRI示蛛网膜下腔侵犯是术后视觉结局的独立负面预测因素。

研究设计与样本

  • 术前及术后3-6个月采用视觉损伤评分评估视力与视野,并应用多因素logistic回归分析视觉结局相关因素。

主要发现

  • 术前视觉损害严重程度为轻度24.3%(9/37)、中度24.3%(9/37)、重度35.1%(13/37)、完全性16.2%(6/37)。
  • 术后视觉功能改善43.2%(16/37)、稳定43.2%(16/37)、恶化13.5%(5/37)。
  • 多因素logistic回归显示蛛网膜下腔侵犯是唯一独立影响术后视觉结局的不良预后因素。
  • 有蛛网膜下腔侵犯者术后视觉恶化可能性更高(36.4% vs. 3.8%;P=0.021)。

临床怎么用

  • 术前MRI评估蛛网膜下腔侵犯有助于识别经颅手术后视觉恶化高风险的大至巨大垂体腺瘤患者。
  • 对存在蛛网膜下腔侵犯的患者,应充分告知术后视觉功能可能恶化的风险。

局限性

  • 样本量较小(37例),结论需更大样本验证。
  • 视觉结局评估时间为术后3-6个月,缺乏更长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Factors associated with visual outcomes after transcranial surgery for large-to-giant pituitary adenomas have not been fully elucidated. METHODS: We recruited 37 patients with large-to-giant pituitary adenomas between January 2014 and December 2016 and assessed their tumor characteristics and surgical outcomes. Visual acuity and visual field were evaluated by visual impairment score before and 3-6 months after transcranial surgery. Multivariable logistic regression analysis was applied to show the factors associated with visual outcomes after surgery. RESULTS: The severity levels of visual impairment before surgery were mild, moderate, severe, and complete in 24.3% (9/37), 24.3% (9/37), 35.1% (13/37), and 16.2% (6/37), respectively. After surgery, the visual function was improved, stabilized, and worsened in 43.2% (16/37), 43.2% (16/37), and 13.5% (5/37) of patients, respectively. Multivariable logistic regression analysis showed that subarachnoid space invasion was the only independent prognostic factor adversely influencing the postoperative visual outcomes. Patients with subarachnoid space invasion had a higher possibility of visual deterioration (36.4% vs. 3.8%; P = 0.021) after transcranial surgery, compared with those without subarachnoid space invasion. CONCLUSIONS: Visual compromise is still an unignorable complication during transcranial surgery for large-to-giant pituitary adenomas. Subarachnoid space invasion indicated by preoperative magnetic resonance imaging was an independent negative predictor for visual outcomes after surgery.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shen M, Chen Z, Shou X, et al. Surgical Outcomes and Predictors of Visual Function Alterations After Transcranial Surgery for Large-to-Giant Pituitary Adenomas. World Neurosurg. 2020. PMID: 32353541. doi:10.1016/j.wneu.2020.04.151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。